Viewing Study NCT03258567

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-03-11 @ 11:39 AM
Study NCT ID: NCT03258567
Status: RECRUITING
Last Update Posted: 2025-12-08
First Post: 2017-08-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epstein-Barr Virus Infections View
None Lymphoma View
None Lymphoproliferative Disorder View
None Disorders, Lymphoproliferative View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Monoclonal Antibody View